SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-042913
Filing Date
2019-11-12
Accepted
2019-11-12 16:10:27
Documents
10
Period of Report
2019-11-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eq-8k_20190930.htm 8-K 52224
2 EX-99.1 eq-ex991_6.htm EX-99.1 141682
3 EX-99.2 eq-ex992_9.htm EX-99.2 19713
4 GRAPHIC gae5x0huqvld000002.jpg GRAPHIC 3244
5 GRAPHIC gae5x0huqvld000005.jpg GRAPHIC 3244
6 GRAPHIC gae5x0huqvld000001.jpg GRAPHIC 3244
7 GRAPHIC gae5x0huqvld000004.jpg GRAPHIC 3244
8 GRAPHIC gebcpgtq344f000001.jpg GRAPHIC 3241
9 GRAPHIC gae5x0huqvld000003.jpg GRAPHIC 3244
10 GRAPHIC gebcpgtq344f000002.jpg GRAPHIC 200216
  Complete submission text file 0001564590-19-042913.txt   518467
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38692 | Film No.: 191209444
SIC: 2834 Pharmaceutical Preparations